Hope for pancreatic cancer 'vaccine as treatment' trial

Doctors in Liverpool are leading a major trial of a vaccine to treat patients with pancreatic cancer.

More than 50 hospitals are taking part in the trial which is part of a new approach to try to stimulate the immune system.

Pancreatic cancer has the poorest survival rate of all common cancers.

Fergus Walsh reports.

  • Subsection
  • Published